POGO

icon-facebook

Satellite Manual

5.1 Palliative Care Overview

5.2 Communication

Communicating honestly with a seriously ill child and his or her family about prognosis and expected disease trajectory is central to excellence in palliative and end-of-life care. Honest prognostic discussions, as difficult as they are, allow the child and family to anticipate what they will likely experience and empowers them to make effective decisions about their ongoing care.  Engaging in these discussions also enables the clinician to explore the family’s goals, needs, hopes and fears.   No parent enjoys talking about the possibility/likelihood that there is no further curative treatment available for their child, however research has taught us that parents want to have these honest discussions with their clinicians.1  At times, your non-verbal is more important than verbal communication. Silence, being present, accessible and approachable are all very important skills for effective communication in pediatric palliative care.

 Advance Care Planning (ACP)
ACP is necessary for any child with advanced cancer. It requires effective communication to clarify the goals of care and establish agreement on appropriate interventions for the child as prognosis changes.  Ideally, ACP discussions should happen early and in a non-urgent fashion to help parents digest complex end-of-life decision-making.  ACP should be implemented even though it is difficult to exactly predict the timing of death.  Important topics to review in ACP include:

  1. Seriousness of illness and disease progression
  2. Expected course, treatment options and risk/benefits to each. 
    1. Treatment options may include palliative chemotherapy, palliative radiation, antibiotics, blood replacement products
    2. How long to continue on and when to limit certain aspects of the treatment plan
    3. Will treatment prolong life but at a cost to suffering?  Will treatment prolong life and improve quality of life?
    4. Benefits and impact of artificial nutrition and hydration at end of life
    5. Reassurance that the child will be offered fluids and foods by mouth for comfort providing ability
  3. Focus on minimizing distress and easing suffering
    1. Review of pain medications and adjuvants
  4. Family-centered care and the focus on siblings
  5. Resuscitation
  6. What does death look like :  included in the section on EOL care

Resuscitation
Resuscitation status is a small but integral part of ACP.  Discussions about resuscitation should be incorporated into the larger issue of goals of care, as the benefits of CPR when goals become focused on optimizing comfort are dubious.  Parents typically obtain their information about resuscitation from the media.  Some parents have expressed worry that “DNR” means “Do Not Treat”; they may have the misperception that if there is a DNR in place, their child will not have access to pain and symptom management and other aspects of supportive care, leading to increased suffering.  Important considerations when communicating about resuscitation include:

  1. Ensure you lead discussions about resuscitation with open ended questions vs asking parents if they want a “DNR”.  Open ended questions allow for deeper and meaningful understanding of what a DNR is and is not. We need to remember that every parent would do anything and everything to save their child. 
  2. CPR will not save the child dying from cancer.
  3. Parents need to understand the futility of attempting resuscitation in a child dying of a malignant disease. They require support and guidance from the medical team to appreciate the pain and suffering (both for the child and family) that often come with resuscitation attempts in a child with advanced cancer and the parental distress of actively withdrawing life sustaining treatment. 
  4. It is crucial to emphasize to parents what WILL be provided – oxygen, medications to keep their child comfortable, and ongoing care and support – not just discuss what we won’t do.

References

  1. Mack JW, Wolfe J, Grier HE, Cleary PD, Weeks JC. Communication about prognosis between parents and physicians of children with cancer: parent preferences and the impact of prognostic information. J. Clin. Oncol. Nov 20 2006;24(33):5265-5270.

Primary authors Ms. Lisa Pearlman, Children’s Hospital, London Health Sciences Centre, London and Ms. Vicky Wilton, Health Sciences North, Sudbury. Reviewed by the POGO Satellite Manual Palliative Care Working Group, 2016.

5.3 Settings of Care
Back to Top

In this Section

  • 1.1 History & Overview
  • 1.2 Acknowledgements
  • 1.3 Committees and Working Groups
  • 1.4 Satellite Manual Disclaimer
  • 2.1 Principles of Satellite Care
  • 2.2 Eligible Patients
    • 2.2.1 Children Eligible for Chemotherapy Administration in a Satellite Centre
    • 2.2.2 Children Not Eligible for Chemotherapy Administration in a Satellite Centre
    • 2.2.3 Children Eligible for the Management of Complications on a Satellite Centre
    • 2.2.4 Eligibility of Children Requiring Supportive Care
  • 2.3 Scope of Satellite Practice
    • 2.3.1 Implementation of Psychosocial Treatment Plan (Process for Communication)
    • 2.3.2 Limitations on Satellite Practice
  • 2.4 Advanced Satellite Practice
  • 3.1 Safe Handling, Administration and Disposal of Chemotherapy Agents
  • 3.2 Accidental Exposure/Spills
  • 3.3 Extravasation Management
    • 3.3.1 Sample Extravasation Documenting Tool
  • 3.4 Injecting SC Medication Via an Insuflon
  • 3.5 Chemotherapy Administration Reference List
  • 3.6 Central Venous Catheter Care
  • 3.7 Chemotherapy Quick Reference
    • 3.7.1 Rapid Hydration Document
    • 3.7.2 Provider Guide: Prevention and Management or Irinotecan induced Diarrhea
    • 3.7.3 Parent Handout: Prevention and Management of Irinotean induced diarrhea
    • 3.7.4 Capizzi Methotrexate
    • 3.7.5 Erwinia L-Asparaginase
  • 4.1 Management of Fever and Neutropenia
    • 4.1.1 Routine Order Sample Sheet
    • 4.1.2 Fever Cards (Sample)
    • 4.1.3 Criteria for low-risk designation. Risk categorization refers to risk of bacteremia and serious complications, including mortality.
  • 4.2 Pentamidine Administration
    • 4.2.1 Inhaled Pentamidine
    • 4.2.2 Intravenous Pentamidine
  • 4.3 Antiemetics
  • 4.4 Treatment of Varicella-Zoster Infections
  • 4.5 TPN Document
  • 4.6 Immunization of Children with Cancer
  • 4.7 Transfusion
  • 4.8 When to consult the Tertiary Centre
  • 5.1 Palliative Care Overview
  • 5.2 Communication
  • 5.3 Settings of Care
  • 5.4 Symptom Management
  • 5.5 End of Life
  • 5.6 When a Child Dies in the Satellite Centre
    • 5.6.1 Reconciling your grief
    • 5.6.2 Funeral arrangement checklist
    • 5.6.3 Helping Children who grieve
    • 5.6.4 Coping with the Holidays
    • 5.6.5 The grieve experience
  • 6.1 Goals and Objectives
  • 6.2 Participant Site Selection
    • 6.2.1 Tertiary Site Selection
    • 6.2.2 Community Site Selection
  • 6.3 POGO’s Roles
    • 6.3.1 PHIPA, Privacy and Research
  • 6.4 Funding
    • 6.4.1 Funding Support for Tertiary Activity
    • 6.4.2 Financial Support for Pediatric Oncology Community Activity
  • 6.5 Infrastructure and Formal Requirements
    • 6.5.1 Tertiary Partners’ Role in Provincial Pediatric Oncology Satellite Program
    • 6.5.2 Satellite Partners’ Role in Provincial Pediatric Oncology Satellite Program
  • 7.1 Preamble
  • 7.2 Investigator responsibilities
  • 7.3 Training Requirements
    • 7.3.1 General Training for Conduct of Research
    • 7.3.2 Protocol Specific Training
  • 7.4 Research Activites that may be completed in satellite centres under supervision of DSI
  • 7.5 Research Activities to be completed in Tertiary Centres Only
  • 7.6 Recognition and Reporting of Adverse Events (AEs)
  • 7.7 Data Transfer
  • 7.8 Pharmacy Drug Accountibility
  • 7.9 Site Inspections and Quality Assurance
  • 8.1 Pediatric Oncology Shared Care Initial Data Transfer Sheet
  • 8.2 Shuttle Sheet
  • 8.3 Psychosocial Communication Tool
  • 9.1 Satellite Readiness/ Preparedness Checklist
  • 9.2 Education Report for Tertiary Centres
  • 9.3 Education Report for Satellite Centres
  • 9.4 Vital Signs Report
  • 9.5 Self- Assessment
  • 9.6 Satellite Contact Form
  • 9.7 Annual Satellite Caseload Report
  • 9.8 POGO Provincial Satellite Program Annual Accounting Report
Back to table of contents
Search our Manual
Have a question?
Contact us at: satellite@pogo.ca
  • About Us
    • Diversity, Equity, Inclusion
    • Childhood Cancer Care Plan
    • Our Mission and Vision
    • Our Board
    • Our Partners
    • Our Donors
    • Privacy
    • History & Milestones
    • Reports
    • Newsroom
    • Job Opportunities
    • Accessibility
    • Staff List
  • Programs & Support
    • Patient Care Programs
    • Financial Assistance
    • Survivor Care
    • Cancer Resources
    • Childhood Cancer Resource Guide
    • Inspiring Stories
    • Clinical and Program Advisory Committees
  • Education
    • POGO AfterCare Education Day
    • POGO Multi-Disciplinary Symposium on Childhood Cancer
    • All Education Events & Conferences
  • Healthcare Practice
    • COVID-19 Updates
    • Pediatric Oncology Nursing
    • Clinical Practice Guidelines
    • Satellite Manual
  • Research & Data
    • 2020 POGO Surveillance Report
    • POGO Research Unit
    • POGONIS – Childhood Cancer Database
    • Data Reports
    • Data Requests
  • Get Involved
    • Pajamas and Pancakes
    • Birthday Parties for POGO
    • Events
    • Volunteer
  • Ways to Give
    • Donate
    • Gifts of Stock and Securities
    • Become a Corporate Partner
    • Gifts in Honour/Memory
    • Legacy Gifts
    • Shop Online/Earn Cash Back

©2020 Pediatric Oncology Group of Ontario

480 University Avenue, Suite 1014 | Toronto, Ontario, M5G 1V2, Canada | Charitable Registration Number: 871067245RR0001 | Contact Us
1-855-FOR POGO (367-7646) | Website Privacy Policy | Website Disclaimer | Satellite Manual Disclaimer |